Legendary TEs Tony Gonzalez, Delanie Walker bringing awareness to prostate cancer testing

Early detection of prostate cancer is key to treatment, and legendary tight ends and working with Novartis to break the ...

Rob Gronkowski Tells Men to ‘Relax Your Tight End’ in Funny PSA for Prostate Cancer Screening (Exclusive)

The funny campaign — “Relax, it’s a Blood Test” — features former and current NFL tight ends like Tony Gonzalez, Colby ...

First Patient Dosed in Pivotal Phase 3 Study of TLX591-Px (Illuccix®) for Prostate Cancer Imaging in Japanese Patients

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the ...

How breast cancer research is helping prostate cancer patients

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Medical Xpress

Prostate cancer cells use unique metabolic pathway to thrive in bone tissue

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...
Frontiers

Bone metastases from endocrine cancer: advances in diagnosis, treatment, and prevention

Endocrine cancers, originating from hormone-producing organs, prefer to metastasize hematogenously to bone as a common site. Once considered rare, diagnosis rate of bone metastases presents a rising ...
TMCnet

Syncromune®, Inc. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Syncromune ®, Inc., a clinical-stage biopharmaceutical company dedicated to the development of SYNC-T, an in situ ...
BioSpace

Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual ...

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Syncromune ®, Inc., a clinical-stage biopharmaceutical company pioneering SYNC-T, an in situ personalized combination ...